These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 27156612)

  • 1. Thermostability of IFN-γ and IP-10 release assays for latent infection with Mycobacterium tuberculosis: A TBnet study.
    Blauenfeldt T; Wagner D; Aabye M; Heyckendorf J; Lange B; Lange C; Ernst M; Ravn P; Duarte R; Morais C; Hoffmann M; Schoch OD; Dominguez J; Latorre I; Ruhwald M
    Tuberculosis (Edinb); 2016 May; 98():7-12. PubMed ID: 27156612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a one-step probe based molecular assay for rapid immunodiagnosis of infection with M. tuberculosis using dried blood spots.
    Blauenfeldt T; Heyckendorf J; Graff Jensen S; Lange C; Drabe C; Hermansen TS; de Thurah L; Lillebaek T; Eugen-Olsen J; Seersholm N; Hoff S; Bonde J; Ruhwald M
    PLoS One; 2014; 9(9):e105628. PubMed ID: 25184553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of IP-10 in Quantiferon-Plus as biomarker for the diagnosis of latent tuberculosis infection.
    Petrone L; Vanini V; Chiacchio T; Petruccioli E; Cuzzi G; Schininà V; Palmieri F; Ippolito G; Goletti D
    Tuberculosis (Edinb); 2018 Jul; 111():147-153. PubMed ID: 30029901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance of Interferon-Gamma and IP-10 Release Assays for Diagnosing Latent Tuberculosis Infections in Patients with Concurrent Malaria in Tanzania.
    Drabe CH; Vestergaard LS; Helleberg M; Nyagonde N; Rose MV; Francis F; Theilgaard OP; Asbjørn J; Amos B; Bygbjerg IC; Ruhwald M; Ravn P
    Am J Trop Med Hyg; 2016 Apr; 94(4):728-35. PubMed ID: 26834199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential Role for Mycobacterium tuberculosis Specific IL-2 and IFN-γ Responses in Discriminating between Latent Infection and Active Disease after Long-Term Stimulation.
    Sun Q; Wei W; Sha W
    PLoS One; 2016; 11(12):e0166501. PubMed ID: 28033330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dried plasma spots in the diagnosis of tuberculosis: IP-10 release assay on filter paper.
    Aabye MG; Latorre I; Diaz J; Maldonado J; Mialdea I; Eugen-Olsen J; Ravn P; Dominguez J; Ruhwald M
    Eur Respir J; 2013 Aug; 42(2):495-503. PubMed ID: 23349445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of IL-2, IL-10, IL-17 and IP-10 as potent discriminative markers for active tuberculosis among pulmonary tuberculosis suspects.
    You E; Kim MH; Lee WI; Kang SY
    Tuberculosis (Edinb); 2016 Jul; 99():100-108. PubMed ID: 27450011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon-gamma inducible protein 10 as a biomarker for active tuberculosis and latent tuberculosis infection in children: a case-control study.
    Alsleben N; Ruhwald M; Rüssmann H; Marx FM; Wahn U; Magdorf K
    Scand J Infect Dis; 2012 Apr; 44(4):256-62. PubMed ID: 22103555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alternative biomarkers for classification of latent tuberculosis infection status in pregnant women with borderline Quantiferon plus results.
    Tesfaye F; Sturegård E; Walles J; Winqvist N; Balcha TT; Karlson S; Mulleta D; Isberg PE; Jansson M; Björkman P
    Tuberculosis (Edinb); 2020 Sep; 124():101984. PubMed ID: 32829076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evolution of IGRA researches].
    Ariga H; Harada N
    Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiplex analysis of plasma cytokines/chemokines showing different immune responses in active TB patients, latent TB infection and healthy participants.
    Yao X; Liu Y; Liu Y; Liu W; Ye Z; Zheng C; Ge S
    Tuberculosis (Edinb); 2017 Dec; 107():88-94. PubMed ID: 29050777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemokines additional to IFN-γ can be used to differentiate among Mycobacterium tuberculosis infection possibilities and provide evidence of an early clearance phenotype.
    Nonghanphithak D; Reechaipichitkul W; Namwat W; Naranbhai V; Faksri K
    Tuberculosis (Edinb); 2017 Jul; 105():28-34. PubMed ID: 28610785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of IFN-γ and IP-10 detection in the diagnosis of latent tuberculosis infection in patients with inflammatory rheumatic diseases.
    Villar-Hernández R; Latorre I; Mínguez S; Díaz J; García-García E; Muriel-Moreno B; Lacoma A; Prat C; Olivé A; Ruhwald M; Mateo L; Domínguez J
    J Infect; 2017 Oct; 75(4):315-325. PubMed ID: 28751171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of a whole-blood chemiluminescent immunoassay of IFN-γ, IP-10, and MCP-1 for diagnosis of active pulmonary tuberculosis and tuberculous pleurisy patients.
    Liang Y; Wang Y; Li H; Yang Y; Liu J; Yu T; Wu X
    APMIS; 2016 Oct; 124(10):856-64. PubMed ID: 27523388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic performance of GM-CSF and IL-2 in response to long-term specific-antigen cell stimulation in patients with active and latent tuberculosis infection.
    Balcells ME; Ruiz-Tagle C; Tiznado C; García P; Naves R
    Tuberculosis (Edinb); 2018 Sep; 112():110-119. PubMed ID: 30205963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PpiA antigen specific immune response is a potential biomarker for latent tuberculosis infection.
    Pathakumari B; Anbarasu D; Parthasarathy RT; Raja A
    Tuberculosis (Edinb); 2015 Dec; 95(6):736-743. PubMed ID: 26546406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Feasibility Study for Diagnosis of Latent Tuberculosis Infection Using an IGRA Point-of-Care Platform in South Korea.
    Hur YG; Hong JY; Choi DH; Kim A; Park SY; Kwon M; Kang K; Lee JM; Dockrell HM; Lee Y; Joo H; Cho SN
    Yonsei Med J; 2019 Apr; 60(4):375-380. PubMed ID: 30900424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mycobacteria-Specific Cytokine Responses Detect Tuberculosis Infection and Distinguish Latent from Active Tuberculosis.
    Tebruegge M; Dutta B; Donath S; Ritz N; Forbes B; Camacho-Badilla K; Clifford V; Zufferey C; Robins-Browne R; Hanekom W; Graham SM; Connell T; Curtis N
    Am J Respir Crit Care Med; 2015 Aug; 192(4):485-99. PubMed ID: 26030187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of mycobacterial bacterioferritin B for immune screening of tuberculosis and latent tuberculosis infection.
    Yang X; Wu JB; Liu Y; Xiong Y; Ji P; Wang SJ; Chen Y; Zhao GP; Lu SH; Wang Y
    Tuberculosis (Edinb); 2017 Dec; 107():119-125. PubMed ID: 29050758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Could inducible protein-10 and heparin-binding hemagglutinin improve the detection of Mycobacterium tuberculosis-infected subjects in a country with low incidence of tuberculosis?
    Molicotti P; Bua A; Cubeddu M; Ruggeri M; Mura MS; Pirina P; Zanetti S
    Infect Dis (Lond); 2015 Aug; 47(8):563-7. PubMed ID: 25856090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.